Results 81 to 90 of about 1,672 (143)
Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence. [PDF]
EBioMedicineHarvey R, Welsh C, Byrne AM, Greenwood D, Stevenson-Leggett P, Galiano M, Bailey D, Chan YW, Boateng J, Wolmuth-Gordon H, Whitaker H, Brown KE, Jeffery-Smith A, Allen A, Amirthanlingam G, Fossum E, Vikse EL, Rohringer A, Hungnes O, Bragstad K, Swanton C, Williams B, Gandhi S, Gamblin S, Carr EJ, Lewis NS, Wall EC, Wu MY, Crick Serology Pipeline, Legacy Investigators. +29 moreeuropepmc +1 more sourceInvestigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021-2024. [PDF]
Emerg Infect DisStevenson-Leggett P, Adams L, Greenwood D, Lofts A, Libri V, Williams B, Gandhi S, Swanton C, Gamblin S, Carr EJ, Harvey R, Lewis NS, Wu MY, Wall EC, Crick Neutralization Consortium, Legacy Investigators, Crick Neutralization Consortium and Legacy Investigators. +16 moreeuropepmc +1 more sourceThe association between iron deficiency and outcomes: a secondary analysis of the intravenous iron therapy to treat iron deficiency anaemia in patients undergoing major abdominal surgery (PREVENTT) trial. [PDF]
Anaesthesia, 2023 Richards T, Miles LF, Clevenger B, Keegan A, Abeysiri S, Rao Baikady R, Besser MW, Browne JP, Klein AA, Macdougall IC, Murphy GJ, Anker SD, Dahly D, PREVENTT trial collaborators. +13 moreeuropepmc +1 more sourceThird exposure to COVID-19 infection or vaccination differentially impacts T cell responses. [PDF]
J InfectAhimbisibwe G, Greenwood D, Wilkinson KA, Gahir J, Townsley H, Miah M, Bawumia P, Chaloner C, Levi D, Hobson P, Riddell A, Hobbs A, Dowgier G, Penn R, Sanderson T, Stevenson-Leggett P, Daley O, Bazire J, Harvey R, Fowler AS, Smith C, Miranda M, O'Reilly N, Warchal S, Ambrose K, Strange A, Kelly G, Kjar S, Legacy Investigators, Williams B, Libri V, Gamblin S, Gandhi S, Swanton C, Bauer DL, Wilkinson RJ, Carr EJ, Wall EC. +37 moreeuropepmc +1 more sourceImmunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis. [PDF]
BMJ Neurol OpenShawe-Taylor MJ, Greenwood D, He A, Hobbs A, Dowgier G, Penn R, Sanderson T, Stevenson-Leggett P, Bazire J, Harvey R, Champsas D, Sharmin S, Aojula A, Bianchi A, Al-Araji S, Hacohen Y, Yam C, Mohamud S, Christensen R, Moccia M, Crick COVID Serology Pipeline, Legacy Investigators, Libri V, Kassiotis G, Gamblin S, Lewis N, Williams B, Swanton C, Gandhi S, Bauer D, Wu M, Carr E, Wall E, Ciccarelli O. +33 moreeuropepmc +1 more sourceAdults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study. [PDF]
BMC MedKwesi-Maliepaard EM, Alhassan Y, Quaye EK, Kotey VM, Mohammed AM, Agyemang S, Sromani AK, Darko S, Buadii E, Tackie R, Akligoh H, Ibrahim B, Hutchful D, Paemka L, Amoako E, Ngoi JM, Manu A, HERITAGE study team, Greenwood D, Carr EJ, Wu MY, Bauer DLV, Wall EC, Crick Legacy Consortium, Dey D, Quao AR, Ayisi A, Amponsa-Achiano K, Bekoe FA, Awandare G, Quashie PK, Bediako Y. +31 moreeuropepmc +1 more sourcePrevalence and Predictors of Barrett's Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases. [PDF]
Clin Gastroenterol HepatolDhaliwal L, Kamboj AK, Williams JL, Chandar AK, Sachdeva K, Gibbons E, Lansing R, Passe M, Perez JA, Avenir KLR, Martin SA, Leggett CL, Chak A, Falk GW, Wani S, Shaheen NJ, Kisiel JB, Iyer PG. +17 moreeuropepmc +1 more sourceDivergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign. [PDF]
LancetShawe-Taylor M, Greenwood D, Hobbs A, Dowgier G, Penn R, Sanderson T, Stevenson-Leggett P, Bazire J, Harvey R, Crick COVID Serology Pipeline Investigators, Legacy Investigators, Libri V, Kassiotis G, Gamblin S, Lewis NS, Williams B, Swanton C, Gandhi S, Carr EJ, Wu MY, Bauer DLV, Wall EC. +21 moreeuropepmc +1 more source
